Dental distribution, with software upside
- Management raised full-year 2026 guidance to $5.29 to $5.39 in non-GAAP diluted EPS.
- Cloud dental software customers generate about $800 in average monthly revenue compared to the $500 company average.
- A $200 million value creation plan is tracking well to deliver savings by the end of 2026.
- Medical sales grew 3.8% in the latest quarter despite ongoing weakness in diagnostic test products.
Guidance raised and software validated
Henry Schein is a large middleman for dental and medical offices. It sells the everyday supplies dentists and doctors use, plus equipment, dental specialty products, and software. The second quarter of 2026 showed strong momentum under new CEO Fred Lowery.
The bull case strengthened after the company raised full-year EPS guidance to a range of $5.29 to $5.39. Management finally shared concrete data on its software transition, revealing that cloud-based Dentrix Ascend users generate about $800 in monthly revenue. This is much higher than the $500 average for older platforms and proves the upgrade cycle is highly profitable.
The bear case is still tied to product headwinds. Demand for point-of-care diagnostics in the Medical segment continues to drag on growth. The company also faces pressure on average selling prices for digital equipment like scanners, which could offset the benefits of higher sales volume.
Supplies first, software next
Henry Schein makes most of its money by buying, warehousing, and selling health care products to office-based dental and medical providers. These products include dental supplies, infection-control items, vitamins, pharmaceuticals, vaccines, diagnostic tests, and equipment.
The company also sells higher-value dental specialty products, such as implants, biomaterials, orthodontics, and endodontic products. These can be more attractive than basic distribution because they are more specialized and less like a simple commodity.
Software is the smaller but more profitable piece. Henry Schein sells practice management software, e-services, and other tools to health care providers. Cloud subscriptions and AI products give the company a path to more recurring revenue. Moving customers to the cloud generates significantly higher monthly revenue per user.
This model can break if dentists and doctors see fewer patients, if customers buy fewer big-ticket equipment items, if product demand swings after a health cycle, or if cost inflation outpaces price increases. It can also break if software growth stays small compared with the much larger distribution base.
What offices buy
Dental merchandise and consumables
This includes dental supplies, infection-control products, PPE, handpieces, composites, anesthetics, and other everyday items. It is the core volume business.
Dental equipment and repair
Henry Schein sells dental chairs, delivery units, lights, X-ray equipment, digital lab tools, and related repair services. Equipment can be more cyclical because offices can delay large purchases.
Medical distribution
The medical side sells branded and generic drugs, vaccines, surgical products, diagnostic tests, and related supplies. This segment has shown weakness tied to lower demand for respiratory test products.
Dental specialty products
This group includes dental implants, biomaterials, endodontic, orthodontic, and orthopedic products. Recent M&A is meant to build out these specialty offerings.
Practice management software
The cloud dental software platform now serves more than 13,000 subscribing practices. Cloud users generate significantly higher monthly revenue than legacy users.
AI products and e-services
Management is launching a new MCP layer to let practices query their own data with AI. The open question is how these tools will be priced and adopted.
Three reported pieces
The segment mix uses net sales from the Q1 2026 Form 10-Q for the three months ended March 28, 2026. Global Distribution and Value-Added Services is much larger than the other two segments, so small changes there can outweigh faster growth in software.
What could go wrong
Medical product cycle fades
Medium impact · Medium oddsThe Medical business faces continued headwinds in point-of-care diagnostic product sales. If another product category rolls over, sales growth could miss guidance.
Digital equipment price pressure
Medium impact · Medium oddsThe company is seeing pressure on average selling prices for digital equipment, especially scanners. If the company cannot sell enough volume to offset these lower prices, equipment revenue will decline.
Efficiency plan misses
High impact · Medium oddsManagement is targeting $125 million of operating income improvement by year-end 2026 as part of a larger $200 million plan. If savings come late or service quality slips, the plan could fail to lift earnings.
Premium implant softness
Medium impact · Low oddsThe United States premium implant market remains softer than Europe. While the value implant market is growing, prolonged weakness in premium products could hurt the Specialty segment margin.
In one breath
What does Henry Schein do?
Henry Schein sells supplies, equipment, specialty dental products, and software to dental and medical offices. It is mainly a health care distributor, with a smaller but growing technology segment.
Is Henry Schein mainly a dental company?
Dental is a large part of the company, but not the only part. The business also features a Global Medical business inside distribution, plus separate Global Specialty Products and Global Technology segments.
Why does software matter for HSIC stock?
Software can be more recurring than product distribution because practices subscribe to tools they use every day. Henry Schein disclosed that its Dentrix Ascend cloud users generate roughly $800 in monthly revenue, well above the $500 company average.
What should investors watch next?
Watch whether management delivers the $125 million operating income improvement target by year-end 2026. Also watch the adoption of new AI tools, Medical sales trends, and whether full-year EPS guidance holds.
